Dokumen

Perbincangan Teknikal Ramalan Bermusim Opsyen

Pemfailan SEC dan dokumen lain Dianthus Therapeutics, Inc.

Terokai dokumen syarikat terkini dan pemfailan SEC dari Dianthus Therapeutics, Inc., termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.

Rakan kongsi data

Huraian

Reported date

Borang

2025

Study Result

Sep 08, 2025

Transcript

Slides

Press release

Q2 2025

Ogos 07, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

Mei 12, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 06, 2025

Transcript

2024

Q4 2024

Mac 11, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Earnings release8-K

Q2 2024

Ogos 08, 2024

Earnings release8-K

Q1 2024

Mei 09, 2024

Earnings release8-K

Corporate Presentation

Mac 14, 2024

Slides

2023

Q4 2023

Mac 21, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 09, 2023

Earnings release8-K

M&A Announcement

Mei 03, 2023

Press release

2022

Q4 2022

Mac 23, 2023

Annual report10-K

Q3 2022

Nov 03, 2022

Earnings release8-K

Q2 2022

Ogos 04, 2022

Earnings release8-K

Q1 2022

Mei 16, 2022

Earnings release8-K

2021

Q4 2021

Mac 08, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 04, 2021

Earnings release8-K

Q2 2021

Ogos 05, 2021

Earnings release8-K

Q1 2021

Mei 06, 2021

Earnings release8-K

2020

Q4 2020

Mac 03, 2021

Annual report10-K

2019

Q4 2019

Mac 03, 2020

Annual report10-K

2018

Q4 2018

Mac 19, 2019

Annual report10-K